Evidence map›Paper›PMID 41419678›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Central amygdalar PKCδ neurons mediate fentanyl withdrawal.

Lisa M Wooldridge, Jacqueline W K Wu, Adrienne Y Jo, Morgan Zinn, Angela M Lee, Malaika Mahmood, Savanna A Cohen, Nora M McCall, Corinna S Oswell, Sophie A Rogers and 1 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lisa M WooldridgeDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jacqueline W K WuDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0009-0006-5179-0964
Adrienne Y JoDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Morgan ZinnDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Angela M LeeDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Malaika MahmoodDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Savanna A CohenDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Nora M McCallDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-5793-1701
Corinna S OswellDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Sophie A RogersDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Gregory CorderDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. gcorder@upenn.edu.ORCID http://orcid.org/0000-0003-0031-0773

Funding

Circuitry dynamics underlying opioid-dependence: Integrating structural, functional, and transcriptomic mechanismsR01DA056599 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI KEVIN T BEIER, Julie A Blendy · 2022 to 2026
$3.8M
Mapping opioid-dependence state transitions across structural, functional, and transcriptomic topologiesR01DA054374 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A, CORDER, GREGORY · 2021 to 2025
$2.4M
Impact of fentanyl dependence on a parabrachio-amygdalar opioid circuitF31DA057795 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI WOOLDRIDGE, LISA · 2023 to 2025
$122k
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) F31DA057795U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R01DA054374U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R01DA056599
6 · The paper itself

Abstract

Aversion to opioid withdrawal is a significant barrier to achieving lasting opioid abstinence. The central amygdala (CeA), a key brain region for pain, threat-detection, autonomic engagement, and valence assignment, is active during opioid withdrawal. However, the role of molecularly distinct CeA neural populations in withdrawal remains underexplored. Here, we investigated the activity dynamics, brain-wide connectivity, and functional contribution of Protein Kinase C-delta (PKCδ)-expressing neurons in the CeA lateral capsule (CeLC

Indexed as

Analgesics, OpioidCentral Amygdaloid NucleusFentanylNeuronsProtein Kinase C-deltaSubstance Withdrawal SyndromeAnimalsMaleMiceMice, Inbred C57BLMice, TransgenicNaloxoneNarcotic AntagonistsAnalgesics, OpioidFentanylNaloxoneNarcotic AntagonistsProtein Kinase C-delta

Identifiers

PMID41419678
PMCPMC13125285

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.